Los puntos clave no están disponibles para este artículo en este momento.
, and 0.7 % to 3.1 % relative to non-doped devices, respectively.
Li et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: